According to Insider Weekends, insider action was quite exciting last week, with buying decreasing from the previous week's $154.2 million to this past week's $85.92 million and selling increasing from $1.06 billion to $2.2 billion.
The report noted that the insider sell/buy ratio was calculated for the prior week at 25.65.
Noteworthy Insider Sells
Atmel Corporation ATML- 997,025 shares for $8.10; Steven Laub, president and CEO
- 252,327 shares for $8.10; Stephen A Skaggs, SVP and CFO
- 225,000 shares for $8.09; Scott M. Wornow, SVP CLO
- 37,600 shares for $321.79; Laurence Fink; chairman and CEO
- 3,161 shares for $313.36; J. Richard Kushel; senior managing director
- 10,400 shares for $1,286.66; Jeffery H. Boyd, director
- 161 shares for $1,283.59; Gillian Trans, president and COO for Booking.com
- 139,980 shares for $57.31; Peter C. Farrell, director
- 36,000 shares for $57.88; Richard Sulpizio, director
- 30,000 shares for $57.61; Brett Sandercock, CFO
- 1,946 shares for $57.06; Anne Reiser, President ResMed Europe
- 110,003 shares for $118.48; Lloyd I. Miller, director
- 11,096 shares for $120.63; Seth Weisberg, CLO
- 5,193 shares for $118.89; VP, Postal Affairs & JP Leon
Noteworthy Insider Buys
Intra-Cellular Therapies Inc ITCI- 100,000 shares at $29.70/share; Christopher D. Alafi, director
- 480,000 shares at $17.82/share; Kevin C. Tang; director
- 2,000 shares at $16.57/share; George F. Tidmarsh; president, CEO and secretary
- 675,922 shares at $31.77/share ; Felix Baker, director
- Purchase made indirectly by Baker Bros. Advisors
- 83,125 shares at $12.03/share; Raymond Debbane, director
- 83,125 shares at $12.04/share; Sacha Lainovic, director
- 50,000 shares at $12.30/share; Christopher J. Sobecki, director
- 30,000 shares at $11.86/share; Philippe Amouyal, director
- 20,000 shares at $12.08/share; Jonas Fajgenbaum, director
- 10,000 shares at $12.69/share; Denis F. Kelly, director
- 795 shares at $12.44/share; Cynthia Elkins, director
- 100,000 shares at $26.63/share; Jeff A. Stevens; president and CEO
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in